HCG Q2 Results: Revenue Growth At 16%, Cash & Insurance Mix Moves Higher | Business News | ET Now
ET Now · 09 Nov 2026 · 5 min
Management interview of HealthCare Global Enterprises Ltd (HCG), with 12 key numbers discussed.
- Manish, HealthCare Global Enterprises Ltd
HealthCare Global Enterprises reported 16% revenue growth and 17% adjusted EBITDA growth in Q2FY27, driven by 9% volume growth and a 7% increase in ARPOB. The company plans to add 1,000 beds by FY30 with an expansion capex of Rs 650 cr, split between greenfield and brownfield projects. Management targets raising the cash and insurance mix to 75% over the next two to three years. The North Bengaluru facility is on track to achieve monthly breakeven by Q4FY27, and management expects no medium-to-long-term impact from drug price caps by FY28.